| Authors: |
Penny LK; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.; Scottish Biologics Facility, University of Aberdeen, Aberdeen, UK.; TauRx Therapeutics Management Ltd., Aberdeen, UK., Arastoo M; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK. mohammad.arastoo@abdn.ac.uk.; Scottish Biologics Facility, University of Aberdeen, Aberdeen, UK. mohammad.arastoo@abdn.ac.uk., Lofthouse R; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.; Scottish Biologics Facility, University of Aberdeen, Aberdeen, UK., Abdallah A; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.; Scottish Biologics Facility, University of Aberdeen, Aberdeen, UK., Imoesi PI; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK., Schwab K; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK., Shiells H; TauRx Therapeutics Management Ltd., Aberdeen, UK., Melis V; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK., Riedel G; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK., Harrington CR; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.; GT Diagnostics (UK) Ltd., Aberdeen, UK.; TauRx Therapeutics Management Ltd., Aberdeen, UK., Wischik CM; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.; GT Diagnostics (UK) Ltd., Aberdeen, UK.; TauRx Therapeutics Management Ltd., Aberdeen, UK., Porter A; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.; Scottish Biologics Facility, University of Aberdeen, Aberdeen, UK., Palliyil S; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.; Scottish Biologics Facility, University of Aberdeen, Aberdeen, UK. |
